InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,035.69
(
-1.57%
)
US TECH 100
16,918.80
(
-2.26%
)
Dow Jones
37,815.92
(
-1.49%
)
Brent Oil
85.66
(
-0.28%
)
Bitcoin
60,122.65
(
-0.79%
)
Post# of 457993
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Pineapple1

Send PM Follow Ignore
Followers 5
Posts 279
Boards Moderated 0
Alias Born 08/29/2015

Pineapple1

Re: nidan7500 post# 357262

Thursday, 04/14/2022 12:10:09 PM

Thursday, April 14, 2022 12:10:09 PM

Post# of 457993
This is not unusual; clinical trials are often stopped when early data suggests a drug will not work.
After our review the committee recommended continuation without changes, most likely the drug is working...
Maybe we should halt the trial, and press the FDA for approval.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!